ARS Pharmaceuticals, Inc. (SPRY) Free Cash Flow

Annual FCF:

$12.98M+$72.43M(+121.85%)
December 31, 2024

Summary

  • As of today, SPRY annual free cash flow is $12.98 million, with the most recent change of +$72.43 million (+121.85%) on December 31, 2024.
  • During the last 3 years, SPRY annual free cash flow has risen by +$30.60 million (+173.71%).
  • SPRY annual free cash flow is now at all-time high.

Performance

SPRY Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYcash flow metrics

Quarterly FCF:

-$47.24M-$7.60M(-19.17%)
September 30, 2025

Summary

  • As of today, SPRY quarterly free cash flow is -$47.24 million, with the most recent change of -$7.60 million (-19.17%) on September 30, 2025.
  • Over the past year, SPRY quarterly free cash flow has dropped by -$32.64 million (-223.43%).
  • SPRY quarterly free cash flow is now -213.29% below its all-time high of $41.70 million, reached on December 31, 2024.

Performance

SPRY Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYcash flow metrics

TTM FCF:

-$86.02M-$32.64M(-61.14%)
September 30, 2025

Summary

  • As of today, SPRY TTM free cash flow is -$86.02 million, with the most recent change of -$32.64 million (-61.14%) on September 30, 2025.
  • Over the past year, SPRY TTM free cash flow has dropped by -$39.99 million (-86.87%).
  • SPRY TTM free cash flow is now -762.44% below its all-time high of $12.98 million, reached on December 31, 2024.

Performance

SPRY TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

SPRY Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+121.8%-223.4%-86.9%
3Y3 Years+173.7%-727.1%-107.2%
5Y5 Years+168.4%--

SPRY Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+121.8%-213.3%at low-762.4%at low
5Y5-Yearat high+121.8%-213.3%at low-762.4%at low
All-TimeAll-Timeat high+121.8%-213.3%at low-762.4%at low

SPRY Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$47.24M(-19.2%)
-$86.02M(-61.1%)
Jun 2025
-
-$39.64M(+2.9%)
-$53.38M(-153.5%)
Mar 2025
-
-$40.83M(-197.9%)
-$21.05M(-262.1%)
Dec 2024
$12.98M(+121.8%)
$41.70M(+385.5%)
$12.98M(+128.2%)
Sep 2024
-
-$14.61M(-99.6%)
-$46.03M(-4.1%)
Jun 2024
-
-$7.32M(-7.7%)
-$44.23M(+17.5%)
Mar 2024
-
-$6.79M(+60.8%)
-$53.61M(+9.8%)
Dec 2023
-$59.44M(-47.6%)
-$17.31M(-35.2%)
-$59.44M(-41.1%)
Sep 2023
-
-$12.81M(+23.3%)
-$42.13M(-20.2%)
Jun 2023
-
-$16.70M(-32.3%)
-$35.03M(-38.3%)
Mar 2023
-
-$12.62M(-121.0%)
-$25.33M(+39.0%)
Dec 2022
-$40.28M
-
-
DateAnnualQuarterlyTTM
Sep 2022
-
-$5.71M(+18.4%)
-$41.51M(+24.5%)
Jun 2022
-
-$7.00M(-0.7%)
-$55.00M(+12.5%)
Mar 2022
-
-$6.95M(+68.2%)
-$62.84M(+7.8%)
Dec 2021
-$17.62M(+45.1%)
-
-
Dec 2021
-
-$21.86M(-13.8%)
-$68.13M(-47.2%)
Sep 2021
-
-$19.21M(-29.5%)
-$46.28M(-70.9%)
Jun 2021
-
-$14.84M(-21.2%)
-$27.07M(-53.1%)
Mar 2021
-
-$12.24M(-124.6%)
-$17.68M(-34.9%)
Dec 2020
-$32.11M(-69.1%)
-
-
Jun 2020
-
-$5.45M(+28.9%)
-$13.11M(-71.1%)
Mar 2020
-
-$7.66M
-$7.66M
Dec 2019
-$18.99M(-9.6%)
-
-
Dec 2018
-$17.32M
-
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is ARS Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is ARS Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of SPRY is $12.98M

What is the all-time high annual free cash flow for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual free cash flow is $12.98M

What is ARS Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, SPRY annual free cash flow has changed by +$72.43M (+121.85%)

What is ARS Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of SPRY is -$47.24M

What is the all-time high quarterly free cash flow for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly free cash flow is $41.70M

What is ARS Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, SPRY quarterly free cash flow has changed by -$32.64M (-223.43%)

What is ARS Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of SPRY is -$86.02M

What is the all-time high TTM free cash flow for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high TTM free cash flow is $12.98M

What is ARS Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, SPRY TTM free cash flow has changed by -$39.99M (-86.87%)
On this page